Tag: KPG-818

Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818

pharmanewsdaily- October 14, 2019

Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of CRL4-CRBN modulator KPG-818 in the US. KPG-818 ... Read More